Conocimientos sobre el virus del papiloma humano y su vacuna en padres de familia de Rivera, Huila en el 2015

Torrado-Arenas, Daniel Mauricio; Álvarez-Pabón, Yelitza; González-Castañeda, Jessica Lorena; Rivera-Contreras, Oscar Eduardo; Sosa-Vesga, Cristian David; González, Brayan Xavier; Sepúlveda-Agudelo, Janer.
Med. UIS ; 30(1): 13-19, ene.-abr. 2017. tab
Artículo en Español | LILACS | ID: biblio-894188

Documentos relacionados

  1. Single-dose HPV vaccine immunity: is there a role for non-neutralizing antibodies?
  2. GARDASIL 9 (Human Papillomavirus 9-Valent Vaccine, Recombinant).
  3. Immunogenicity of a quadrivalent human papillomavirus vaccine in pediatric kidney and liver transplant recipients.
  4. Was amorphous aluminium hydroxyphosphate sulfate adequately evaluated before authorisation in Europe?
  5. The effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules.
  6. Social considerations affecting acceptance of HPV vaccination in Colombia. A systematic review
  7. A vacinação do HPV e o sintoma: aproximações entre Foucault e a psicanálise
  8. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study.
  9. Analysis of Memory B-Cell Responses Reveals Suboptimal Dosing Schedule of a Licensed Vaccine.
  10. Long-term Antibody Response to Human Papillomavirus Vaccines: Up to 12 Years of Follow-up in the Finnish Maternity Cohort.